DUREZOL

Drug Novartis Pharmaceuticals Corporation
Total Payments
$801,041
Transactions
10,074
Doctors
4,618
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2020 $922.67 27 26
2019 $241,851 3,179 1,955
2018 $171,500 3,460 2,136
2017 $386,767 3,408 2,252

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $308,303 95 38.5%
Food and Beverage $199,871 9,785 25.0%
Space rental or facility fees (teaching hospital only) $172,100 61 21.5%
Consulting Fee $73,930 21 9.2%
Travel and Lodging $46,837 112 5.8%

Top Doctors Receiving Payments for DUREZOL — Page 3

Doctor Specialty Location Total Records
, O.D Optometrist New York, NY $293.78 20
, O.D Corneal and Contact Management New York, NY $293.78 20
, MD Internal Medicine Chicago, IL $293.54 4
, M.D Ophthalmology Towson, MD $282.63 19
, M.D Ophthalmology Orange, CA $280.71 22
, MD Retina Specialist Bogalusa, LA $276.55 4
, M.D Ophthalmology Lafayette, LA $275.43 6
, M.D Ophthalmology White Plains, NY $271.30 25
Desirae Brinkley Optometrist Memphis, TN $267.97 7
, OD Optometrist Chicago, IL $266.58 2
, OD Optometrist Davie, FL $266.58 2
, OD Optometrist Davie, FL $266.58 2
, OD Optometrist Miami, FL $266.58 2
, OD Optometrist Davie, FL $266.58 2
, OD Vision Therapy Davie, FL $266.58 2
, DO Student in an Organized Health Care Education/Training Program San Antonio, TX $266.58 2
, OD Optometrist Davie, FL $266.58 2
, MD Ophthalmology Berwyn, IL $265.17 3
, MD Retina Specialist Miami, FL $258.35 2
, MD Ophthalmology Miami, FL $258.35 2
, M.D Ophthalmology New York, NY $257.87 18
, M.D Ophthalmology Baton Rouge, LA $257.35 6
, M.D Ophthalmology New York, NY $248.86 2
, M.D Ophthalmology Miami, FL $248.86 2
, M D Ophthalmology New York, NY $248.86 2

About DUREZOL

DUREZOL is a drug associated with $801,041 in payments to 4,618 healthcare providers, recorded across 10,074 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.

Payment data is available from 2017 to 2020. In 2020, $922.67 was paid across 27 transactions to 26 doctors.

The most common payment nature for DUREZOL is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($308,303, 38.5% of total).